title: Candida utilis candidaemia in neonatal patients.
abstract: In recent years, an evident rise in the frequency of candidaemia caused by non-albicans Candida species has been reported. In this paper we present three cases of clinically manifested candidaemia caused by Candida utilis in neonatal patients hospitalized in the same neonatal intensive care unit within a 6 month period. To the authors' knowledge, only two cases of C. utilis candidaemia have been reported in the literature to date, but neither of these involved newborns. Clinical resolution and elimination of C. utilis from the blood were achieved using liposomal amphotericin B or caspofungin in all patients.
authors.affiliation: Department of Medical Microbiology and Parasitology, University of Zagreb Medical School, Šalata 3, 10 000 Zagreb, Croatia.|Sisters of Mercy University Hospital, Children's Hospital Zagreb, Klaićeva 16, 10 000 Zagreb, Croatia.
authors.forename: Amarela
authors.initials: A
authors.lastname: Lukić-Grlić
authors.affiliation: National Reference Centre for Diagnosis of Systemic Mycoses, Croatian National Institute of Public Health, Rockefellerova 2, 10 0000 Zagreb, Croatia.
authors.forename: Emilija
authors.initials: E
authors.lastname: Mlinarić-Missoni
authors.affiliation: Sisters of Mercy University Hospital, Children's Hospital Zagreb, Klaićeva 16, 10 000 Zagreb, Croatia.
authors.forename: Ivančica
authors.initials: I
authors.lastname: Škarić
authors.affiliation: National Reference Centre for Diagnosis of Systemic Mycoses, Croatian National Institute of Public Health, Rockefellerova 2, 10 0000 Zagreb, Croatia.
authors.forename: Verica
authors.initials: V
authors.lastname: Važić-Babić
authors.affiliation: Laboratory for Biology and Microbial Genetics, Faculty of Food Technology and Biotechnology, Pierottijeva 6, 10 000 Zagreb, Croatia.
authors.forename: Ivan-Krešimir
authors.initials: IK
authors.lastname: Svetec
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage; D000935:Antifungal Agents / Q000008:administration & dosage; D002175:Candida / Q000302:isolation & purification*; D058387:Candidemia / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D000077336:Caspofungin; D054714:Echinocandins / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D055666:Lipopeptides; D008297:Male; D058889:Molecular Typing; D016533:Mycological Typing Techniques; D019105:Random Amplified Polymorphic DNA Technique; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; C068538:liposomal amphotericin B; D000666:Amphotericin B; D000077336:Caspofungin